<VariationArchive RecordType="classified" VariationID="1700250" VariationName="NM_003925.2:c.1699_1701del" VariationType="Deletion" Accession="VCV001700250" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-06-04" DateCreated="2022-08-15" MostRecentSubmission="2022-08-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1692644" VariationID="1700250">
      <GeneList>
        <Gene Symbol="MBD4" FullName="methyl-CpG binding domain 4, DNA glycosylase" GeneID="8930" HGNC_ID="HGNC:6919" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>3q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="129430947" stop="129439948" display_start="129430947" display_stop="129439948" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="129149792" stop="129158851" display_start="129149792" display_stop="129158851" Strand="-" />
          </Location>
          <OMIM>603574</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003925.2:c.1699_1701del</Name>
      <VariantType>Deletion</VariantType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003925.2" sequenceAccession="NM_003925" sequenceVersion="2" change="c.1699_1701delATG">
            <Expression>NM_003925.2:c.1699_1701delATG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603574.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003925.2:c.1699_1701del AND Tumor predisposition syndrome 2" Accession="RCV002274498" Version="1">
        <ClassifiedConditionList TraitSetID="79260">
          <ClassifiedCondition DB="MedGen" ID="C5774186">Tumor predisposition syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-08-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-08-15" MostRecentSubmission="2022-08-15">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30049810</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="79260" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="65696" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MBD4-ASSOCIATED NEOPLASIA SYNDROME</ElementValue>
                <XRef Type="MIM" ID="619975" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tumor predisposition syndrome 2</ElementValue>
                <XRef ID="MONDO:0859267" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TPDS2</ElementValue>
                <XRef Type="MIM" ID="619975" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MANS</ElementValue>
                <XRef Type="MIM" ID="619975" DB="OMIM" />
              </Symbol>
              <XRef ID="C5774186" DB="MedGen" />
              <XRef ID="MONDO:0859267" DB="MONDO" />
              <XRef Type="MIM" ID="619975" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5007152" SubmissionDate="2022-08-08" DateLastUpdated="2022-08-15" DateCreated="2022-08-15">
        <ClinVarSubmissionID localKey="603574.0001_TUMOR PREDISPOSITION SYNDROME 2" title="MBD4, 3-BP DEL, 1699ATG (rs775848563)_TUMOR PREDISPOSITION SYNDROME 2" />
        <ClinVarAccession Accession="SCV002559249" DateUpdated="2022-08-15" DateCreated="2022-08-15" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a man (EMC-AML-1) with tumor predisposition syndrome-2 (TPDS2; 619975) who was diagnosed with acute myelogenous leukemia (AML) at age 33 years, Sanders et al. (2018) identified a germline homozygous in-frame 3-bp deletion (c.1699_1701delATG, NM_003925.2) in the MBD4 gene, resulting in the deletion of residue His567 (H567del) in the glycosylase domain. The mutation was found by whole-exome sequencing and confirmed by Sanger sequencing. In vitro functional expression studies showed that deletion of His567 resulted in a complete loss of MBD4 catalytic activity. Despite 2 hematopoietic stem cell transplants, the AML was refractory to treatment and recurred, resulting in death several years after initial diagnosis. The patient also had a prior history of multiple colonic polyps requiring hemicolectomy.</Attribute>
              <Citation>
                <ID Source="PubMed">30049810</ID>
              </Citation>
              <XRef DB="OMIM" ID="619975" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MBD4" />
          </GeneList>
          <Name>MBD4, 3-BP DEL, 1699ATG (rs775848563)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 1699ATG (rs775848563)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603574.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TUMOR PREDISPOSITION SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5007152" TraitType="Disease" MappingType="Name" MappingValue="TUMOR PREDISPOSITION SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C5774186" Name="Tumor predisposition syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

